Infectious Disease Diagnostics
Infectious Disease Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Assays & Reagents, Kits, Consumables, Instruments and Software & Services), Disease (Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections and Other Infectious Diseases), Technology (Immunodiagnostics, Microbiology, Polymerase Chain Reaction, Next-generation Sequencing and Other Technologies), End User and By Geography
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $23.63 billion in 2024 and is expected to reach $42.78 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Infectious disease diagnostics refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a person's body to diagnose infectious diseases. These diagnostics involve various techniques and methods aimed at detecting specific pathogens or their markers, often through analyzing bodily fluids, tissues, or other samples. Rapid diagnostic tests (RDTs) are also utilized for quick identification in settings with limited resources. Accurate and timely diagnosis of infectious diseases is crucial for effective patient management, initiation of appropriate treatment, implementation of infection control measures, and disease surveillance.
According to the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that approximately 1.7 million infections and 99,000 associated deaths occur every year in American hospitals. According to the U.S. Food and Drug Administration (FDA), in 2020, it was reported that around 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year.
Market Dynamics:
Driver:
Growing demand for point-of-care testing
Point-of-care testing offers rapid, convenient, and decentralized testing solutions, allowing for quick diagnosis and timely treatment decisions at the patient's bedside or in community settings. This shift towards POCT is driven by several factors, including the need for faster turnaround times, especially in infectious disease outbreaks or pandemics like COVID-19. Additionally, POCT reduces the burden on centralized laboratory facilities and healthcare infrastructure, making testing more accessible to underserved populations and remote areas.
Restraint:
High cost of diagnostic tests
The high cost of diagnostic tests poses a significant barrier to the growth of the Infectious Disease Diagnostics Market. These costs encompass various aspects such as test development, manufacturing, and distribution, all of which contribute to the final price borne by patients and healthcare systems. For many individuals, especially in low- and middle-income countries, these expenses are prohibitive, leading to delayed or missed diagnoses and subsequent treatment. However, high costs can strain healthcare budgets, limiting access to essential diagnostic services.
Opportunity:
Rise in public health awareness
The rise in public health awareness has substantially contributed to the growth of the Infectious Disease Diagnostics Market. With an increasing understanding of the importance of early detection and prevention of infectious diseases, individuals and governments alike are investing more resources into diagnostic technologies. The global health crises, such as the COVID-19 pandemic, have highlighted the critical role of diagnostic testing in containing outbreaks and guiding public health responses. Consequently, there is a growing emphasis on the development and adoption of rapid, accurate, and cost-effective diagnostic solutions, driving innovation in the infectious disease diagnostics market and fostering collaborations between healthcare providers, research institutions and diagnostic companies.
Threat:
Complexity of diagnostic procedures
The complexity of diagnostic procedures poses a significant obstacle in the growth of the Infectious Disease Diagnostics Market. These complexities encompass various facets, including the technical intricacies involved in testing methodologies, lengthy turnaround times for obtaining results, and the requirement for skilled personnel to perform and interpret tests accurately. However, the diversity of infectious agents and their evolving nature further complicates diagnostic protocols, necessitating continuous updates and adaptations to detection techniques. These complexities not only increase the cost burden on healthcare systems but also impede timely and effective diagnosis and treatment of infectious diseases.
Covid-19 Impact:
The Covid-19 pandemic significantly impacted the infectious disease diagnostics market. There was an unprecedented surge in demand for diagnostic tests to detect the virus, leading to a rapid expansion of the market. The pandemic highlighted the importance of diagnostic testing in controlling infectious diseases, leading to increased investment in research and development for novel diagnostic technologies. However, the pandemic also disrupted supply chains and distribution networks, causing temporary shortages of testing kits and reagents.
The Fungal Infections segment is expected to be the largest during the forecast period
The fungal infections segment is anticipated to be the largest in the infectious disease diagnostics market during the forecast period due to the rising prevalence of invasive fungal diseases, particularly among immunocompromised individuals. Increased awareness, advancements in diagnostic technologies, and the need for timely and accurate identification of fungal pathogens drive market growth. The growing incidence of hospital-acquired infections and the high morbidity and mortality rates associated with fungal infections further contribute to the segment's expansion.
The Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period
Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period by enabling rapid and comprehensive analysis of pathogens' genetic material. This technology allows for the simultaneous detection and characterization of multiple infectious agents, including bacteria, viruses, fungi, and parasites, in a single test. By sequencing the entire genome or specific regions of pathogens, NGS can provide valuable insights into their genetic diversity, drug resistance profiles, and epidemiological patterns. This comprehensive approach enhances the accuracy and efficiency of infectious disease diagnosis, particularly in cases where traditional methods may fail to identify the causative agent or distinguish between closely related strains. Additionally, NGS facilitates the detection of emerging infectious diseases and the monitoring of outbreaks in real-time, empowering healthcare professionals to implement timely and targeted interventions for better disease management and control.
Region with largest share:
Asia Pacific region commanded the largest share of the market throughout the extrapolated period. As populations age, there's a natural increase in susceptibility to infectious diseases due to weakened immune systems and other age-related factors. This demographic shift creates a higher demand for diagnostic tools and services to effectively detect and manage infectious diseases among the elderly. Additionally, factors such as urbanization, changing lifestyles, and increased access to healthcare facilities further contribute to the expansion of the infectious disease diagnostics market in the region.
Region with highest CAGR:
Europe region is poised to hold profitable growth during the projection period. Through stringent regulatory frameworks, such as the European Union's In Vitro Diagnostic Regulation (IVDR), authorities ensure the quality, safety, and efficacy of diagnostic tests. These regulations not only set high standards for product development and manufacturing but also facilitate timely approvals and market access for innovative diagnostic technologies. Moreover, compliance with these regulations fosters trust among healthcare professionals and patients, thereby driving the regional adoption of advanced diagnostic solutions.
Key players in the market
Some of the key players in Infectious Disease Diagnostics market include Bio-Rad Laboratories, Inc, Hologic, Inc, Luminex Corporation, Abbott Laboratories, GenMark Diagnostics, Inc, PerkinElmer, Inc, Thermo Fisher Scientific Inc, Bruker Corporation, Sysmex Corporation, Nanosphere Health Sciences Inc, Trinity Biotech plc, InBios International, Inc and Meridian Bioscience, Inc.
Key Developments:
In February 2023, Abbott to acquire Cardiovascular Systems for $837.6 mln. The deal will help Abbott gain access to CSI's minimally invasive device to treat blocked arteries.
In May 2022, Quidel Corporation a US-based company that provides rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, has acquired Ortho Clinical Diagnostics and the succeeding business groups.
Products Covered:
• Assays & Reagents
• Kits
• Consumables
• Instruments
• Software & Services
Diseases Covered:
• Bacterial Infections
• Viral Infections
• Fungal Infections
• Parasitic Infections
• Other Diseases
Technologies Covered:
• Immunodiagnostics
• Microbiology
• Polymerase Chain Reaction
• Next-generation Sequencing
• Other Technologies
End Users Covered:
• Diagnostic Laboratories
• Academic Research Institutes
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Infectious Disease Diagnostics Market, By Product
5.1 Introduction
5.2 Assays & Reagents
5.3 Kits
5.4 Consumables
5.5 Instruments
5.6 Software & Services
6 Global Infectious Disease Diagnostics Market, By Disease
6.1 Introduction
6.2 Bacterial Infections
6.3 Viral Infections
6.4 Fungal Infections
6.5 Parasitic Infections
6.6 Other Infectious Diseases
7 Global Infectious Disease Diagnostics Market, By Technology
7.1 Introduction
7.2 Immunodiagnostics
7.3 Microbiology
7.4 Polymerase Chain Reaction
7.5 Next-generation Sequencing
7.6 Other Technologies
8 Global Infectious Disease Diagnostics Market, By End User
8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Academic Research Institutes
8.4 Hospitals
8.5 Other End Users
9 Global Infectious Disease Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Bio-Rad Laboratories, Inc
11.2 Hologic, Inc
11.3 Luminex Corporation
11.4 Abbott Laboratories
11.5 GenMark Diagnostics, Inc
11.6 PerkinElmer, Inc
11.7 Thermo Fisher Scientific Inc
11.8 Bruker Corporation
11.9 Sysmex Corporation
11.10 Nanosphere Health Sciences Inc
11.11 Trinity Biotech plc
11.12 InBios International, Inc
11.13 Meridian Bioscience, Inc
List of Tables
1 Global Infectious Disease Diagnostics Market Outlook, By Region (2022-2030) ($MN)
2 Global Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
3 Global Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
4 Global Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
5 Global Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
6 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
7 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
8 Global Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
9 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
10 Global Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
11 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
12 Global Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
13 Global Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
14 Global Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
15 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
16 Global Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
17 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
18 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
19 Global Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
20 Global Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
21 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
22 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
23 Global Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
24 Global Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
25 North America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
26 North America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
27 North America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
28 North America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
29 North America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
30 North America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
31 North America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
32 North America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
33 North America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
34 North America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
35 North America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
36 North America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
37 North America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
38 North America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
39 North America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
40 North America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
41 North America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
42 North America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
43 North America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
44 North America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
45 North America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
46 North America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
47 North America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
48 North America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
49 Europe Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
50 Europe Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
51 Europe Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
52 Europe Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
53 Europe Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
54 Europe Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
55 Europe Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
56 Europe Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
57 Europe Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
58 Europe Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
59 Europe Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
60 Europe Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
61 Europe Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
62 Europe Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
63 Europe Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
64 Europe Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
65 Europe Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
66 Europe Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
67 Europe Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
68 Europe Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
69 Europe Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
70 Europe Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
71 Europe Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
72 Europe Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
73 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
74 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
75 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
76 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
77 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
78 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
79 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
80 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
81 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
82 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
83 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
84 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
85 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
86 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
87 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
88 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
89 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
90 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
91 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
92 Asia Pacific Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
93 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
94 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
95 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
96 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
97 South America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
98 South America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
99 South America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
100 South America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
101 South America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
102 South America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
103 South America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
104 South America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
105 South America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
106 South America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
107 South America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
108 South America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
109 South America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
110 South America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
111 South America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
112 South America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
113 South America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
114 South America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
115 South America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
116 South America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
117 South America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
118 South America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
119 South America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
120 South America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
121 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
122 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
123 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
124 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
125 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
126 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
127 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
128 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
129 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
130 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
131 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
132 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
133 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
134 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
135 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
136 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
137 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
138 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
139 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
140 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
141 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
142 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
143 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
144 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
